Oregon Cancer

News and information for cancer services throughout Oregon.

  • Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

    Read Article
  • New research lab will focus on improving treatments for soft tissue sarcoma

    New research lab will focus on improving treatments for soft tissue sarcoma

    Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

    Read Article
  • Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

    Read Article
  • Boost cancer prevention and survival through Asian nutritional diet

    Boost cancer prevention and survival through Asian nutritional diet

    Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.

    Read Article
  • Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference

    Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference

    Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.

    Read Article
  • Two studies assess combination treatments for advanced breast cancers

    Two studies assess combination treatments for advanced breast cancers

    Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

    Read Article
  • Hotspot TCR-T study of gene-engineered adoptive cell therapy for incurable cancers

    Hotspot TCR-T study of gene-engineered adoptive cell therapy for incurable cancers

    Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.

    Read Article
  • Creating Hope 2022 introduces next generation of immunotherapy

    Creating Hope 2022 introduces next generation of immunotherapy

    A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.

    Read Article
  • Advances in early-phase clinical trials help develop new cancer therapies

    Advances in early-phase clinical trials help develop new cancer therapies

    With the advent of personalized medicine, the need for more sophisticated early-phase clinical trials is increasing.

    Read Article
  • Learn about ovarian cancer treatment and research at virtual patient education event

    Learn about ovarian cancer treatment and research at virtual patient education event

    Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.

    Read Article
  • Clinical trials: Leading breakthroughs in cancer research

    Clinical trials: Leading breakthroughs in cancer research

    May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

    Read Article
  • Studies will evaluate combination therapies for two types of melanoma

    Studies will evaluate combination therapies for two types of melanoma

    Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

    Read Article
  • Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

    Read Article
  • New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

    Read Article
  • Study to evaluate effect of immunotherapy in blood cancer

    Study to evaluate effect of immunotherapy in blood cancer

    A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.

    Read Article
  • Community events focus on pancreatic cancer research and awareness

    Community events focus on pancreatic cancer research and awareness

    Providence Cancer Institute of Oregon and Pancreatic Cancer Action Network are partnering to promote awareness and research for pancreatic cancer through two community events this April.

    Read Article
  • Three studies concentrate on personalized treatment for colon cancer

    Three studies concentrate on personalized treatment for colon cancer

    Clinical studies focus on finding new ways to treat colorectal cancer, prevent recurrence and improve survival outcomes.

    Read Article
  • Meet Dr. Hagen Kennecke: Following his passion to advance cancer care

    Meet Dr. Hagen Kennecke: Following his passion to advance cancer care

    Providence medical oncologist and medical director of gastrointestinal oncology talks about his career in oncology and his passion for cancer research.

    Read Article
  • Providence oncologist named 2022 Woman of the Year

    Providence oncologist named 2022 Woman of the Year

    Providence medical oncologist Dr. Janet Ruzich was honored by the Leukemia & Lymphoma Society in a special awards ceremony in May.

    Read Article
  • Three studies focus on improving treatments for gastrointestinal cancers

    Three studies focus on improving treatments for gastrointestinal cancers

    People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new clinical trials available at Providence Cancer Institute of Oregon.

    Read Article
  • loading
    Loading More...